Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition and Safety in Patients With Cervical Dystonia

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02175693

Enrollment

1647

Registered

2014-06-26

Start date

2013-04-02

Completion date

2019-06-30

Last updated

2020-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Dystonia

Keywords

Torticollis, rimabotulinumtoxinB

Brief summary

Investigation of the clinical condition and safety in patients with cervical dystonia

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

Patients with cervical dystonia

Exclusion criteria

The patients who participated in this surveillance in the past

Design outcomes

Primary

Measure	Time frame	Description
Overall assessments of the improvement in the seriousness of seizures	Up to 3 years	Improvement is based on the 5 following elements: 1) Eminent improvement 2) Improvement 3) Improvement a little invariability 5) Exacerbation 6) It is not possible to judge

Countries

Japan

Outcome results